Inhibrx
AcquiredLa Jolla, United States · $240.0M raised
- Headquarters
- La Jolla, California
- Employees
- 51–200
- Business Model
- B2B
- Total Funding
- $240.0M
- Last Round
- $200.0M Corporate RoundAug 2023
- Rounds
- 2
About
Clinical-stage biotechnology company utilizing protein engineering to develop biologic therapeutic candidates.
Summary
Inhibrx is a Biotech company based in La Jolla, United States. It has raised $240.0M in total across 2 rounds, most recently a $200.0M Corporate Round round in Aug 2023. Investors include Sanofi Ventures and Viking Global.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...